Information was received from a patient (pt) via manufacturer representative (rep) who was implanted with an implantable neurostimul ator (ins).It was reported that there was a suspected csf leak for which they are doing mri.Reviewed language in mri guidelines about doing mri scan on pt who recently was implanted.Pt presented some time after implant with headache, nausea, dizziness (exact timing not known).Caller notified yesterday by pt that pt was in hospital due to this health issue.Caller unsure which healthcare provider (hcp) is working with pt.Rep doesn't know which day pt was admitted to hospital.Additional information was received from the rep and it was reported that according to the patient a csf leak was discovered.Caffeine iv drip and pain medication was administered.The issue is not resolved.However, he feels better than he did when it first happened.The patient said the doctors said it will resolve on its own.
|
Corrections: d10 concomitant product, e1 initial reporter, g2 report source, and additional code crrected.Continuation of d10: product id 977a260 lot# serial# (b)(6).Implanted: (b)(6) 2021 explanted: (b)(6) 2021 product type lead product id 977a260 lot# serial# (b)(6) implanted: (b)(6) 2021 explanted: (b)(6) 2021 product type lead medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|